{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T02:35:16Z","timestamp":1778121316513,"version":"3.51.4"},"reference-count":0,"publisher":"Portico","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1358\/dot.2015.51.9.2368554","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T11:12:07Z","timestamp":1573038727000},"page":"519","source":"Crossref","is-referenced-by-count":12,"title":["Empagliflozin: A new treatment option for patients with type 2\ndiabetes mellitus"],"prefix":"10.3730","volume":"51","author":[{"family":"G.E. Dailey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1320","published-online":{"date-parts":[[2015]]},"container-title":["Drugs of Today"],"original-title":[],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T13:19:44Z","timestamp":1685452784000},"score":1,"resource":{"primary":{"URL":"http:\/\/access.portico.org\/stable?au=pjbf7dd2vb6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":0,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1358\/dot.2015.51.9.2368554","relation":{},"ISSN":["1699-4019"],"issn-type":[{"value":"1699-4019","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}